About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  QUARTERLY RESULTS
Quarterly Results      
Ajanta Pharma Ltd.
BSE Code 532331
ISIN Demat INE031B01049
Book Value 350.00
NSE Code AJANTPHARM
Dividend Yield % 0.98
Market Cap 356360.13
P/E 37.79
EPS 75.48
Face Value 2  
Quarters :
(Rs. in Millions)
Particulars (Rs in Million) Dec 2025Sep 2025Jun 2025Mar 2025
 Audited / UnAudited UnAudited UnAudited UnAudited UnAudited
Net Sales 12065.90 12202.40 12085.60 10139.40
Total Expenditure 8656.40 9306.50 8791.60 7642.90
PBIDT (Excl OI) 3409.50 2895.90 3294.00 2496.50
Other Income 257.60 750.30 406.30 179.30
Operating Profit 3667.10 3646.20 3700.30 2675.80
Interest 18.70 7.30 7.30 6.70
Exceptional Items 0 0 0 0
PBDT 3648.40 3638.90 3693.00 2669.10
Depreciation 423.80 419.20 403.10 387.60
Profit Before Tax 3224.60 3219.70 3289.90 2281.50
Tax 774.20 724.40 740.20 347.20
Provisions and contingencies 0 0 0 0
Profit After Tax 2450.40 2495.30 2549.70 1934.30
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0.00 0.00 0.00 0.00
Net Profit 2450.40 2495.30 2549.70 1934.30
Equity Capital 250.70 250.70 250.70 250.70
Face Value (IN RS) 2 2 2 2
Reserves    
Calculated EPS 19.55 19.91 20.34 15.43
Calculated EPS (Annualised) 78.19 79.63 81.36 61.72
No of Public Share Holdings 42171847.00 42171847.00 42148322.00 42148322.00
% of Public Share Holdings 33.75 33.75 33.74 33.74
     
PBIDTM% (Excl OI) 28.26 23.73 27.26 24.62
PBIDTM% 30.39 29.88 30.62 26.39
PBDTM% 30.24 29.82 30.56 26.32
PBTM% 26.72 26.39 27.22 22.50
PATM% 20.31 20.45 21.10 19.08
 Notes Notes Notes Notes
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.